Figure and Table Legend
Figure 1: Cellular and humoral response to fourth SARS-CoV-2 vaccine
dose in individual patients including patient characteristics (entity,
treatment, time from treatment to vaccination in days). Fold change of
specific T-cell proliferation (CD4+,
CD8+) after stimulation with spike protein (S) and RBD
Hu-1 and total IgG against spike, RBD Hu-1, and RBD Omicron. Fold change
>1.1 is considered response to vaccination.
Table 1: Patientsā characteristics. 1m = male,2COVID-19 vaccines used for homologous or heterologous
vaccination regimen: AZD=ChAdOx1, BnT= BNT162b2, Mod= mRNA-1273,3Time between third COVID-19 vaccination and blood
sampling prior fourth vaccination, 4Time between
fourth COVID-19 vaccination and blood sampling after fourth vaccination,5Time between last cancer therapy and fourth COVID-19
vaccination, *FOLFOX = folic acid, 5-fluorouracil plus oxaliplatin,+FERRERI= methotrexate, cytarabine, thiotepa plus
rituximab, #FOLFIRI= folic acid, 5-fluorouracil plus
irinotecan